> top > docs > PMC:7461420 > spans > 87345-87864 > annotations

PMC:7461420 / 87345-87864 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T413 402-406 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1004 157-158 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T1005 336-339 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T10086 110-115 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T554 374-379 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T48660 443-447 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2699 402-410 Species denotes SARS‐CoV Tax:694009

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T758 0-150 Sentence denotes Drug repurposing is an attractive strategy for finding new indications for already well‐established, marketed drugs or highly characterized compounds.
T759 151-315 Sentence denotes It is a fast way to identify of new therapeutic options directly available for clinical use or eligible for accelerated approval for various diseases and disorders.
T760 316-413 Sentence denotes An extensive effort has been made in repurposing approved drugs since the outbreak of SARS‐CoV‐1.
T761 414-519 Sentence denotes Below, we summarize selected drug repositioning strategies for anticoronaviral therapy and their results.